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Summary 
 
 Pregnant gilts were infected at 90 days of 
gestation with porcine reproductive and respira-
tory virus (PRRSV) isolate SD-23983. Fetuses 
recovered between 109 and 112 days of gesta-
tion were analyzed for the presence of PRRSV.  
The results showed that not all fetuses were  
infected, and that infected fetuses tended to be 
clustered within the uterine horns, suggesting 
that virus is spread from fetus to fetus. Even 
though affected litters exhibited different de-
grees of gross pathology, the presence of an 
anatomical abnormality was not an identifier of 
an infected fetus. Analysis of virus replication 
in individual tissues identified the thymus as the 
principal site of PRRSV replication.  The results 
show that PRRSV infection in the developing 
fetus follows a unique course and that PRRSV-
induced alterations may be the result of the ef-
fect of PRRSV on maternal tissues. These fac-
tors need to be taken into consideration when 
diagnosing PRRSV infection as the cause for 
aborted and stillborn fetuses. 
 
(Key Words:  Porcine Reproductive and Respi-
ratory Syndrome Virus, PRRS, Diagnostics, Fe-
tal Infection.) 
 
Introduction 
 
 At present, porcine reproductive and respira-
tory syndrome (PRRS) is responsible for incur-
ring approximately $600 million a year in losses 
to producers. The reproductive form of PRRS is 
initiated by the infection of pregnant gilts/sows 
at about 90 days of gestation.  Outcomes range 
from aborted and stillborn fetuses to piglets that 
are born live, but weak, with mortality some-
times approaching 100%. The impact of infec-
tion continues through the nursery and finishing 
stages and contributes to clinical respiratory dis-
ease development and mortality.  Preventing 
reproductive PRRS is a key element in the re-
duction of losses that result from PRRS. The 
purpose of this study was to characterize sites of 
virus replication and sources of pathology in the 
PRRS-affected fetus. 
 
Procedures 
 
 All animal procedures were reviewed and 
approved by the Kansas State University Ani-
mal Care and Use Committee.  Four pregnant 
gilts, obtained from a closely monitored 
PRRSV-negative herd, were infected at 90 days 
of gestation with a sixth-passage isolate of 
SDSU-23983, a typical North American field 
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isolate.  Three milliliters of virus, at a concen-
tration of 104 TCID50/ml, was divided into two 
doses and administered into each nare with a 3-
ml syringe or was injected intramuscularly.  
Two mock-infected gilts served as a sources for 
normal fetuses. At between 108 and 111 days of 
gestation, gilts were sacrificed and both uterine 
horns were removed.  Each fetus was individu-
ally removed. The location within the uterine 
horn and gross pathology, if present, were re-
corded, and fetuses were immediately necrop-
sied. Amniotic fluid and blood were collected 
first. Tissues for virus isolation (VI)  and histo-
pathology included lung, heart, placenta, um-
bilical cord and the lymphoid-associated  tis-
sues, tonsil, thymus, mandibular lymph nodes, 
and inguinal lymph nodes.  Virus isolation was 
performed by using standard techniques, and 
results were reported as the log10 of the inverse 
dilution of the last positive well per 1.0 ml of 
serum or gram of tissue.  The PRRSV-specific 
antibody was measured in sera by using the 
HerdCheck® PRRS ELISA (IDEXX). Tissue 
samples were collected and immediately placed 
in 10% buffered formalin. Paraffin-embedded 
thin sections were mounted on slides processed 
for staining with hematoxylin and eosin (H and 
E).  Immunohistochemical staining for PRRSV 
nucleocapsid antigen was performed by the di-
agnostic laboratory.   
 
Results and Discussion 
 
 Clinical signs during infection of gilts were 
minimal. A total of 44 fetuses were recovered 
from the four infected gilts. Within one to two 
weeks after challenge, all infected gilts became 
VI-positive in serum, confirming the presence 
of an active infection.  Three of the four in-
fected gilts seroconverted, as indicated by a 
PRRSV ELISA S/P ratio greater than 0.39. 
Gross pathology was observed in all of the in-
fected litters (Figure 1), including poorly devel-
oped or dead fetuses, abnormalities in amniotic 
fluid and placenta. A total of 24 fetuses were 
obtained from the two control gilts. All control 
fetuses seemed normal, except for two mummi-
fied fetuses, one less than 5 cm in length. Virus 
titers in serum and tissues and serology from 
infected fetuses and dams are presented in Fig-
ure 1 and Table 1. Ten of the 42 (24%) viable 
fetuses were positive for PRRSV by VI in se-
rum. Infection was further confirmed by posi-
tive VI and immunohistochemistry (IHC) results 
from selected tissues. The number of infected 
fetuses in each litter ranged from no infected 
fetuses (dam No. 174) to 5 infected fetuses (dam 
No. 85).    Fetuses that were VI-negative in se-
rum were confirmed as PRRSV-negative by 
negative results for placenta, lung, lymph nodes, 
and thymus.   Seven of the 10 infected fetuses 
showed some form of gross pathology.  Ongo-
ing virus replication in the fetus as the source of 
these changes is questionable, however, because 
non-infected fetuses from infected gilts exhib-
ited some form of damage (Figure 1).  For in-
stance, the litter from dam No. 174, which was 
not infected, contained fetuses that were dead or 
exhibited some form of gross anatomical 
change. This observation suggests that maternal 
changes that result from infection are sources of 
fetal damage.  
 
 To identify the targets of virus replication in 
the fetus, a variety of tissues were assessed for 
the presence of virus and virus-infected cells. 
The results are presented in Table 1. Positive VI 
results were obtained from 6 of 10 lungs, 5 of 
10 lymph nodes, 6 of 10 tonsils, and 9 of 10 
thymuses. Within this group of tissues, the thy-
mus contained the greatest quantity of virus. For 
instance, six thymuses yielded virus titers 
greater than 103/gram. The greatest numbers of 
antigen-positive slides were also found from 
thymus (Table 1).  Considered together, these 
data identify the thymus as a primary site of vi-
rus replication in the PRRSV-infected fetus. 
 
 The results presented in this study describe 
several unique features of fetal PRRSV  
infection, which have important implications in 
the diagnosis of PRRSV as a cause of abortion. 
 6
First, not all fetuses are infected. Therefore, 
when performing VI or PCR to detect virus, 
several affected fetuses should be collected 
and/or samples should be pooled from several 
fetuses. Fetuses should be randomly selected 
and should include fetuses that seem “normal”.  
Tissues chosen for VI or PCR analysis should 
include thymus.  Thoracic fluid, a readily avail-
able source of serum and tissue fluid, is also a 
good source of virus and antibody. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Dams 
Dam 
No. 
 Virus 
Isolation 
Antibody 
(S/P ratio) 
 
4410 
 
 
 
neg. 
 
1.07 
 
 
 
174 
 
 
 
 
 
 
 
neg. 
 
 
 
0.37 
 
 
 
179 
 
 
 
 
 
 
 
neg. 
 
 
 
1.4 
 
 
 
 
85 
 
 
 
 
 
 
 
 
 
neg. 
 
 
 
 
0.53 
VI-negative VI-positive Dead (not tested) Seropositive  
Figure 1.  Location of Infected Fetuses Within the Uterine Horns.   The identification number, VI, 
and serology data for each dam are on the right. Each circle represents the relative location of each fetus 
in the left and right uterine horns. The number above each fetus identifies the order of removal and the 
number used to identify fetuses in the text and in Table 1. Clear circles represent non-infected fetuses. 
The VI titer (the number below each shaded fetus), and serology (the numbers in parentheses) were per-
formed on serum. Dead fetuses (black circles) were autolysed and not tested.   
 Gross Pathology Key 
  *1 Partly mummified 
  *2 Nonviable fetus or excessively small amounts of amniotic fluid 
  *3 Necrotic placenta 
  *4 Meconium- and/or blood-stained amniotic fluid 
  *5 Small fetus 
Left uterine horn               Right uterine horn 
     7    8      9      10   11    12               6      5      4      3      2      1 
   1         2       3                   8        7      6      5    4
       3.0     2.0 
      (0.02)  (0.94) 
    7      8      9      10     11    12            6       5      4      3      2     1 
    1.4           2.1    1.4 
  (0.03)        (0.04) (0.00) 
 8    9       10       11     12      13    14         7        6      5      4      3      2     1 
      2.1     2.1     2.1      2.1     2.1 
   (0.00) (0.00) (0.00) (0.03) (0.00) 
Fetuses 
*1                   *2                                                *3   *2
*4   *4                               *2                                 *2     *2    *2     *5
                *4     *4      *4                                                                  *1
      *5                   *4                                                                  *5             
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Table 1.  PRRS Virus Isolation and Immunohistochemistry (IHC) in Fetal Tissues1 
Dam No.   4410   179   85 
Fetus No. 2 3 9 11 12 9 10 11 12 13 
Placenta 
 
3.6 n.m.2 1.0 1.6 1.9 2.4 n.m. n.m. 2.7 1.3 
Umbilical cord 
 
n.d.3 1.4 1.3 2.2 1.6 2.2 2.0 1.2 1.1 1.9 
Heart 
 
1.7 1.8 2.5 2.6 1.4 2.8 n.m. 1.3 1.0 2.0 
Lung 
 (IHC) 
 
2.1 
(-)4 
n.m. 
(-) 
1.0 
(-) 
n.m. 
(-) 
n.m. 
(-) 
0.8 
(-) 
n.m. 
(-) 
0.7 
(-) 
0.5 
(-) 
1.9 
(-) 
Lymph node5 
 (IHC) 
  
3.6 
(-) 
n.m. 
(-) 
2.2 
n.d. 
2.2 
(-) 
n.m. 
n.d. 
3.0 
(-) 
n.m. 
(-) 
n.m. 
(+) 
1.3 
(-) 
n.m. 
(+) 
Spleen 
 (IHC) 
 
2.3 
(-) 
n.m. 
(-) 
2.1 
(-) 
3.1 
(-) 
2.1 
(-) 
2.7 
(-) 
1.9 
(-) 
1.0 
(-) 
n.m. 
(-) 
1.6 
(+) 
Tonsil 
 (IHC) 
 
1.3 
(-)  
1.4 
(-) 
1.2 
(n.d.) 
1.2 
(-) 
2.2 
(-) 
3.2 
(-) 
n.m 
(-). 
n.m. 
(-) 
n.m. 
(-) 
n.m. 
(-) 
Thymus 
 (IHC) 
4.1 
(+) 
n.m. 
(-) 
1.6 
(-) 
2.3 
(+) 
3.6 
(+) 
1.6 
(+) 
3.5 
(+) 
3.5 
(+) 
2.2 
(+) 
4.2 
(+) 
1The VI results are presented as virus titer per gram of tissue.   
2n.m.: Not measured.  VI-negative at a dilution of 1:5. 
3n.d.: Not determined.  
4For lung, tonsil, and thymus tissues, the symbol in parenthesis indicates the presence (+) or absence (-) of cells 
positive for PRRSV antigen.  The PRRSV antigen was detected by using immunohistochemistry as described in 
Figure 2. The results indicate the results obtained for a single thin section. 
5Virus isolation was performed on mandibular lymph node. Immunohistochemistry data, in parentheses, include 
results for both mandibular and medial inguinal lymph nodes. A (+) indicates the presence of at least one PRRSV-
positive cell. 
 
